124 related articles for article (PubMed ID: 23180436)
1. Effector mechanisms of sunitinib-induced G1 cell cycle arrest, differentiation, and apoptosis in human acute myeloid leukaemia HL60 and KG-1 cells.
Teng CL; Yu CT; Hwang WL; Tsai JR; Liu HC; Hwang GY; Hsu SL
Ann Hematol; 2013 Mar; 92(3):301-13. PubMed ID: 23180436
[TBL] [Abstract][Full Text] [Related]
2. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic aspects of lauryl gallate-induced differentiation and apoptosis in human acute myeloid leukemia cells.
Teng CL; Han SM; Wu WC; Hsueh CM; Tsai JR; Hwang WL; Hsu SL
Food Chem Toxicol; 2014 Sep; 71():197-206. PubMed ID: 24994563
[TBL] [Abstract][Full Text] [Related]
4. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
5. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells.
Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X
Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib Inhibits Breast Cancer Cell Proliferation by Inducing Apoptosis, Cell-cycle Arrest and DNA Repair While Inhibiting NF-κB Signaling Pathways.
Korashy HM; Maayah ZH; Al Anazi FE; Alsaad AM; Alanazi IO; Belali OM; Al-Atawi FO; Alshamsan A
Anticancer Res; 2017 Sep; 37(9):4899-4909. PubMed ID: 28870911
[TBL] [Abstract][Full Text] [Related]
7. The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells.
Opydo-Chanek M; Cichoń I; Rak A; Kołaczkowska E; Mazur L
Invest New Drugs; 2020 Dec; 38(6):1664-1676. PubMed ID: 32367199
[TBL] [Abstract][Full Text] [Related]
8. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
Zheng R; Wang X; Studzinski GP
J Steroid Biochem Mol Biol; 2015 Apr; 148():132-7. PubMed ID: 25448741
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of ZD1839-induced G1-cell cycle arrest and apoptosis in human lung adenocarcinoma A549 cells.
Chang GC; Hsu SL; Tsai JR; Liang FP; Lin SY; Sheu GT; Chen CY
Biochem Pharmacol; 2004 Oct; 68(7):1453-64. PubMed ID: 15345335
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumor activity of Antrodia salmonea in human promyelocytic leukemia (HL-60) cells is mediated via the induction of G₁ cell-cycle arrest and apoptosis in vitro or in vivo.
Hseu YC; Lee CC; Chen YC; Kumar KJ; Chen CS; Huang YC; Hsu LS; Huang HC; Yang HL
J Ethnopharmacol; 2014 Apr; 153(2):499-510. PubMed ID: 24631961
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
Meinhardt G; Roth J; Totok G
Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
[TBL] [Abstract][Full Text] [Related]
13. Icariside II induces cell cycle arrest and differentiation via TLR8/MyD88/p38 pathway in acute myeloid leukemia cells.
Yang J; Lan J; Du H; Zhang X; Li A; Zhang X; Liu Y; Zhang J; Zhang C; Ding Y; Zhang T
Eur J Pharmacol; 2019 Mar; 846():12-22. PubMed ID: 30579933
[TBL] [Abstract][Full Text] [Related]
14. AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia.
Eriksson A; Kalushkova A; Jarvius M; Hilhorst R; Rickardson L; Kultima HG; de Wijn R; Hovestad L; Fryknäs M; Öberg F; Larsson R; Parrow V; Höglund M
Biochem Pharmacol; 2014 Jan; 87(2):284-91. PubMed ID: 24200998
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
Wu CL; Ping SY; Yu CP; Yu DS
Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
[TBL] [Abstract][Full Text] [Related]
16. Meisoindigo is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia.
Lee CC; Lin CP; Lee YL; Wang GC; Cheng YC; Liu HE
Leuk Lymphoma; 2010 May; 51(5):897-905. PubMed ID: 20233051
[TBL] [Abstract][Full Text] [Related]
17. Sunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myelogenous leukemia cells that is enhanced by 1,25-dihydroxyvitamin D(3).
Nishioka C; Ikezoe T; Yang J; Yokoyama A
Leukemia; 2009 Nov; 23(11):2171-3. PubMed ID: 19657366
[No Abstract] [Full Text] [Related]
18. Beta-mangostin from Cratoxylum arborescens activates the intrinsic apoptosis pathway through reactive oxygen species with downregulation of the HSP70 gene in the HL60 cells associated with a G
Omer FAA; Hashim NBM; Ibrahim MY; Dehghan F; Yahayu M; Karimian H; Salim LZA; Mohan S
Tumour Biol; 2017 Nov; 39(11):1010428317731451. PubMed ID: 29110583
[TBL] [Abstract][Full Text] [Related]
19. Monensin-mediated growth inhibition in acute myelogenous leukemia cells via cell cycle arrest and apoptosis.
Park WH; Lee MS; Park K; Kim ES; Kim BK; Lee YY
Int J Cancer; 2002 Sep; 101(3):235-42. PubMed ID: 12209973
[TBL] [Abstract][Full Text] [Related]
20. Blockade of MEK/ERK signaling enhances sunitinib-induced growth inhibition and apoptosis of leukemia cells possessing activating mutations of the FLT3 gene.
Nishioka C; Ikezoe T; Yang J; Takeshita A; Taniguchi A; Komatsu N; Togitani K; Koeffler HP; Yokoyama A
Leuk Res; 2008 Jun; 32(6):865-72. PubMed ID: 17983653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]